UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c

Cell metabolism, 2012-05, Vol.15 (5), p.725-738

2012

Volltextzugriff (PDF)

Mechano-modulatory synthetic niches for liver organoid derivation

Nature communications, 2020-07, Vol.11 (1), p.3416-3416, Article 3416

2020

Volltextzugriff (PDF)

MicroRNAs 103 and 107 regulate insulin sensitivity

Nature (London), 2011-06, Vol.474 (7353), p.649-653

2011

Volltextzugriff (PDF)

Growth of Epithelial Organoids in a Defined Hydrogel

Advanced materials (Weinheim), 2018-10, Vol.30 (43), p.e1801621-n/a

2018

Volltextzugriff (PDF)

Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA

Science (American Association for the Advancement of Science), 2014-03, Vol.343 (6176), p.1221-1228

2014

Volltextzugriff (PDF)

The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota

Science translational medicine, 2014-05, Vol.6 (237), p.237ra66

2014

Volltextzugriff (PDF)

Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model

PLoS computational biology, 2022-09, Vol.18 (9), p.e1009767-e1009767

2022

Volltextzugriff (PDF)

Host – hepatitis C viral interactions: The role of genetics

Journal of hepatology, 2016-10, Vol.65 (1), p.S22-S32

2016

Volltextzugriff (PDF)

Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver

Hepatology (Baltimore, Md.), 2014-06, Vol.59 (6), p.2121-2130

2014

Volltextzugriff (PDF)

YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors

Hepatology (Baltimore, Md.), 2015-11, Vol.62 (5), p.1497-1510

2015

Volltextzugriff (PDF)

Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages

Nature communications, 2022-05, Vol.13 (1), p.2436-2436, Article 2436

2022

Volltextzugriff (PDF)

Interferon signaling and treatment outcome in chronic hepatitis C

Proceedings of the National Academy of Sciences - PNAS, 2008-05, Vol.105 (19), p.7034-7039

2008

Volltextzugriff (PDF)

Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls

PloS one, 2015-11, Vol.10 (11), p.e0143293-e0143293

2015

Volltextzugriff (PDF)

OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease

PloS one, 2020-07, Vol.15 (7), p.e0236447-e0236447

2020

Volltextzugriff (PDF)

Studying Hepatitis Virus-Host Interactions in Patient Liver Biopsies

Viruses, 2022-11, Vol.14 (11), p.2490

2022

Volltextzugriff (PDF)

Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease

PloS one, 2014-01, Vol.9 (1), p.e87488-e87488

2014

Volltextzugriff (PDF)

Hepatitis C Virus (HCV) Induces Formation of Stress Granules Whose Proteins Regulate HCV RNA Replication and Virus Assembly and Egress

Journal of Virology, 2012-10, Vol.86 (20), p.11043-11056

2012

Volltextzugriff (PDF)

Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver

EMBO molecular medicine, 2017-06, Vol.9 (6), p.816-834

2017

Volltextzugriff (PDF)

Innate and adaptive immune responses in HCV infections

Journal of hepatology, 2014-11, Vol.61 (1), p.S14-S25

2014

Volltextzugriff (PDF)

Clinical course of infection and viral tissue tropism of hepatitis C virus–like nonprimate hepaciviruses in horses

Hepatology (Baltimore, Md.), 2015-02, Vol.61 (2), p.447-459

2015

Volltextzugriff (PDF)

Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient

Proceedings of the National Academy of Sciences - PNAS, 2016-02, Vol.113 (5), p.1381-1386

2016

Volltextzugriff (PDF)

25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end

Nature reviews. Immunology, 2013-07, Vol.13 (7), p.535-542

Heim, Markus H

2013

Volltextzugriff (PDF)

Management of hepatocellular carcinoma: SASL expert opinion statement

Swiss medical weekly, 2020-07, Vol.150 (3132), p.w20296

2020

Volltextzugriff (PDF)

Interferon‐inducible cholesterol‐25‐hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation

Hepatology (Baltimore, Md.), 2015-09, Vol.62 (3), p.702-714

2015

Volltextzugriff (PDF)

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(248)
Mit Volltextzugriff
(215)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Hepatology
(30)
Gastroenterology
(12)
Journal Of Hepatology
(12)
Cytokine
(10)
Nature Communications
(10)
Journal Of Virology
(9)
Blood
(8)
Plos One
(8)
Swiss Medical Weekly
(8)
Proceedings Of The National Academy Of Sciences - Pnas
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c

Mechano-modulatory synthetic niches for liver organoid derivation

MicroRNAs 103 and 107 regulate insulin sensitivity

Growth of Epithelial Organoids in a Defined Hydrogel

Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA

The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota

Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model

Host – hepatitis C viral interactions: The role of genetics

Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver

YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors

Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages

Interferon signaling and treatment outcome in chronic hepatitis C

Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls

OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease

Studying Hepatitis Virus-Host Interactions in Patient Liver Biopsies

Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease

Hepatitis C Virus (HCV) Induces Formation of Stress Granules Whose Proteins Regulate HCV RNA Replication and Virus Assembly and Egress

miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis

Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver

Innate and adaptive immune responses in HCV infections

Clinical course of infection and viral tissue tropism of hepatitis C virus–like nonprimate hepaciviruses in horses

Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient

25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end

Management of hepatocellular carcinoma: SASL expert opinion statement

Interferon‐inducible cholesterol‐25‐hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation

Suchergebnisse filtern